RE:RE:RE:RE:RE:RE:RE:RE:RE:good luckCashie-poo, darling, I am myself. I've been here since "the first time TOS got their FDA clearance" in mid 2016 and attended the investor meeting at the hotel on the ocean in January of 2017. I am relatively long and have bought-in multiple times. But I am also menopausal, angry and increasingly impatient: How can you
not be angry at this company's performance?
The bashing and diatribes do get tiresome to read indeed, but so do the endless, undeserving accolades and patience for this company's current set of executives and much needed positive sales results.
Somewhere in the middle is reality.
Blu makes good points and you make good points. The only difference between Blu's speculation and yours is that reality has demonstrated the opposite of your theories. You and Wong have all book smarts, perhaps - but no street smarts.
I would love to see this SP soar to $20. That's where it should be.
GLTA and bonne anne.
-AE
Dr.Cash wrote: over as blu, aime and what other names